Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study

scientific article published on 01 December 1999

Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0735-1097(99)00448-9
P698PubMed publication ID10588212

P2093author name stringJ Willeit
S Kiechl
G Egger
C J Wiedermann
S Dunzendorfer
P Schratzberger
F Oberhollenzer
P2860cites workThe Measurement of Observer Agreement for Categorical DataQ26778373
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy menQ29619308
Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old)Q34086738
Inducible interleukin-1 gene expression in human vascular smooth muscle cellsQ34548807
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell coculturesQ35768215
Novel vascular molecule involved in monocyte adhesion to aortic endothelium in models of atherogenesis.Q36377355
Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarctionQ37880581
Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future researchQ37881887
Chronic infections and coronary heart disease: is there a link?Q37882245
Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study GroupQ37882250
Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarctionQ37882420
Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid arteryQ37886058
Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factorsQ37886448
Association of Prior Infection With Chlamydia pneumoniae and Angiographically Demonstrated Coronary Artery DiseaseQ37892814
Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart StudyQ37893723
Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery diseaseQ37894988
The pathogenesis of atherosclerosis--an updateQ39726917
Dose-response relationship to inhaled endotoxin in normal subjectsQ40645332
Periodontal disease and cardiovascular diseaseQ41204551
Atherogenic Diets Enhance Endotoxin-Stimulated Interleukin-1 and Tumor Necrosis Factor Gene Expression in Rabbit AortaeQ42468058
Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC studyQ45221518
Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study.Q50919576
Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis.Q51012002
Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis. A population-based study.Q51055733
Lipopolysaccharide induces hyperadhesion of endothelial cells for neutrophils leading to damage.Q54626960
Cumulative Effects of High Cholesterol Levels, High Blood Pressure, and Cigarette Smoking on Carotid StenosisQ57746052
Cigarettes are a rich source of bacterial endotoxinQ70993324
Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomyQ71210092
Does atherosclerosis have an infectious etiology?Q71493511
Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention TrialQ71512983
Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjectsQ73832958
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectendotoxemiaQ5832599
cardiovascular diseaseQ389735
P304page(s)1975-1981
P577publication date1999-12-01
P1433published inJournal of the American College of CardiologyQ2984355
P1476titleAssociation of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study
P478volume34

Reverse relations

cites work (P2860)
Q366216311,25(OH)2D3 downregulates the Toll-like receptor 4-mediated inflammatory pathway and ameliorates liver injury in diabetic rats.
Q577921245,2'-dibromo-2,4',5'-trihydroxydiphenylmethanone attenuates LPS-induced inflammation and ROS production in EA.hy926 cells via HMBOX1 induction
Q42291031A Novel ASK Inhibitor AGI-1067 Inhibits TLR-4-Mediated Activation of ASK1 by Preventing Dissociation of Thioredoxin from ASK1.
Q61883672A central role for monocytes in Toll-like receptor-mediated activation of the vasculature
Q34084463A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese
Q98196693A possible beneficial effect of Bacteroides on faecal lipopolysaccharide activity and cardiovascular diseases
Q42122755Abnormal macrophage response to microbial stimulus in a 43-year-old man with a severe form of atherosclerosis: a case report
Q37240994Absence of TRAM restricts Toll-like receptor 4 signaling in vascular endothelial cells to the MyD88 pathway
Q33940856Activated TLR signaling in atherosclerosis among women with lower Framingham risk score: the multi-ethnic study of atherosclerosis
Q92860877Adaptation and memory in immune responses
Q34963676Adiponectin protein exists in aortic endothelial cells
Q37574992Advances in Gut Microbiome Research, Opening New Strategies to Cope with a Western Lifestyle
Q59798581Altered gut microbiota after traumatic splenectomy is associated with endotoxemia
Q47099574Anti-inflammatory evaluation of the methanolic extract of Taraxacum officinale in LPS-stimulated human umbilical vein endothelial cells
Q57457620Are toll-like receptors potential drug targets for atherosclerosis? Evidence from genetic studies to date
Q37079653Association of soluble endotoxin receptor CD14 and mortality among patients undergoing hemodialysis
Q36025615Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.
Q90361660Blood Microbiota Modification After Myocardial Infarction Depends Upon Low-Density Lipoprotein Cholesterol Levels
Q34571191Blood microbiota dysbiosis is associated with the onset of cardiovascular events in a large general population: the D.E.S.I.R. study
Q58106596C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet
Q35197222Cardiovascular complications in inflammatory bowel disease.
Q37401827Cationic peptide mR18L with lipid lowering properties inhibits LPS-induced systemic and liver inflammation in rats
Q54233821Circulating Bacterial Fragments as Cardiovascular Risk Factors in CKD.
Q35641502Circulating bacterial-derived DNA fragment level is a strong predictor of cardiovascular disease in peritoneal dialysis patients
Q53039065Consumption of a High-fat Meal was associated with an Increase in Monocyte Adhesion Molecules, Scavenger Receptors, and Propensity to Form Foam Cells.
Q30318502Contribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis
Q37869369Detection of Chlamydiae pneumoniae but not Helicobacter pylori DNA in atherosclerosis plaques
Q35087841Diabetic complications and dysregulated innate immunity
Q36456727Differential TNF production by monocyte subsets under physical stress: blunted mobilization of proinflammatory monocytes in prehypertensive individuals
Q33633640Effects of C-reactive Protein and Homocysteine on Cytokine Production: Modulation by Pravastatin
Q40638929Effects of Porphyromnonas gingivalis lipopolysaccharide on the expression of RANTES and fractalkine in human urnbilical vein endothelial cells
Q34061842Elevated levels of circulating DNA in cardiovascular disease patients: metagenomic profiling of microbiome in the circulation
Q34785885Endotoxemia and the host systemic response during experimental gingivitis
Q33901115Endotoxemia is associated with acute coronary syndrome in patients with end stage kidney disease
Q36666840Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients
Q42540372Endotoxin increase after fat overload is related to postprandial hypertriglyceridemia in morbidly obese patients
Q51538107Endotoxin, Toll-like Receptor-4, and Atherosclerotic Heart Disease.
Q73250265Endotoxin: another phantom menace?
Q53882623Endovascular stent-graft placement versus conventional open surgery in infrarenal aortic aneurysm: a prospective study on acute phase response and clinical outcome.
Q35622521Examining associations of circulating endotoxin with nutritional status, inflammation, and mortality in hemodialysis patients
Q33821397Fecal microbiota transplantation in metabolic syndrome: History, present and future
Q26748713Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease
Q26747585Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats
Q23919376Gender differences in the effect of occupational endotoxin exposure on impaired lung function and death: the Shanghai Textile Worker Study
Q57623228Gene polymorphisms contributing to hypertension in immunoglobulin A nephropathy
Q52680146Gut Microbiome in Chronic Kidney Disease.
Q38836354Gut microbiome in chronic kidney disease: challenges and opportunities
Q35573510Gut microbiota and diabetes: from pathogenesis to therapeutic perspective.
Q88687570Gut-derived lipopolysaccharides increase post-prandial oxidative stress via Nox2 activation in patients with impaired fasting glucose tolerance: effect of extra-virgin olive oil
Q59822020High fat diet induced atherosclerosis is accompanied with low colonic bacterial diversity and altered abundances that correlates with plaque size, plasma A-FABP and cholesterol: a pilot study of high fat diet and its intervention with Lactobacillus r
Q39396961IL-35, as a newly proposed homeostasis-associated molecular pattern, plays three major functions including anti-inflammatory initiator, effector, and blocker in cardiovascular diseases.
Q34908689IL-6 serum levels and production is related to an altered immune response in polycystic ovary syndrome girls with insulin resistance
Q37871384Immune activation as effect modifier of atherogenesis in chronic infection
Q39808961Immunity in young adult survivors of childhood leukemia is similar to the elderly rather than age-matched controls: Role of cytomegalovirus
Q91845019Immunity, microbiota and kidney disease
Q35819570Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk
Q34381887Impact of contaminated dialysate on long-term haemodialysis-related complications: is it really that important?
Q43703996Induction of apoptosis and inhibition of migration of inflammatory and vascular wall cells by cerivastatin
Q37969996Infectious complications in dialysis--epidemiology and outcomes
Q45979250Inflammation and exercise: Inhibition of monocytic intracellular TNF production by acute exercise via β2-adrenergic activation.
Q38370895Inflammation-induced foam cell formation in chronic inflammatory disease.
Q38020262Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia
Q34841012Innate immune programing by endotoxin and its pathological consequences
Q47363732Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation
Q38757951Intestinal Barrier Disturbances in Haemodialysis Patients: Mechanisms, Consequences, and Therapeutic Options.
Q35725309Is the gut microbiota a new factor contributing to obesity and its metabolic disorders?
Q50333030L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils.
Q34880667Lipopolysaccharide regulated protein expression is only partly impaired in monocytes from patients with type I diabetes
Q42500474Lipopolysaccharide represses the expression of ATP-binding cassette transporter G1 and scavenger receptor class B, type I in murine macrophages
Q33655219Lipopolysaccharide-binding protein is associated with arterial stiffness in patients with type 2 diabetes: a cross-sectional study.
Q84005774Lipopolysaccharide-induced proliferation of the vasa vasorum in a rabbit model of atherosclerosis as evaluated by contrast-enhanced ultrasound imaging and histology
Q37597310Liver X Receptor: Crosstalk Node for the Signaling of Lipid Metabolism, Carbohydrate Metabolism, and Innate Immunity
Q33997331Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia
Q36599048Low-grade inflammatory polarization of monocytes impairs wound healing
Q57117141Metabolic Surgery for the Treatment of Diabetes Mellitus Positioning of Leading Medical Associations in Mexico
Q33713895Microbial translocation and cardiometabolic risk factors in HIV infection
Q36558287Microbial translocation in the pathogenesis of HIV infection and AIDS.
Q37299999Modulation of anti-inflammatory response in lipopolysaccharide stimulated human THP-1 cell line and mouse model at gene expression level with indigenous putative probiotic lactobacilli
Q36534100Molecular mechanisms responsible for the reduced expression of cholesterol transporters from macrophages by low-dose endotoxin
Q36084187Molecular mechanisms responsible for the selective and low-grade induction of proinflammatory mediators in murine macrophages by lipopolysaccharide
Q34966302Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to inflammation
Q35261976Myocardial fibrosis induced by exposure to subclinical lipopolysaccharide is associated with decreased miR-29c and enhanced NOX2 expression in mice
Q58580826New insights on atherosclerosis: A cross-talk between endocannabinoid systems with gut microbiota
Q44307940Nicotine inhibits cardiac apoptosis induced by lipopolysaccharide in rats
Q61798990Novel reprogramming of neutrophils modulates inflammation resolution during atherosclerosis
Q35213837Obesity, inflammation, and the gut microbiota
Q90659422Phenylbutyrate facilitates homeostasis of non-resolving inflammatory macrophages
Q40809002Pilot experience with opebacan/rBPI 21 in myeloablative hematopoietic cell transplantation
Q74137367Plasma concentrations of bacterial lipopolysaccharide: a marker of infection or inflammation?
Q37762605Polyphenols from red wine are potent modulators of innate and adaptive immune responsiveness.
Q36012378Postprandial Effect of a High-Fat Meal on Endotoxemia in Arab Women with and without Insulin-Resistance-Related Diseases.
Q42069466Potent suppression of arginase 1 expression in murine macrophages by low dose endotoxin
Q34667902Recurrent exposure to subclinical lipopolysaccharide increases mortality and induces cardiac fibrosis in mice
Q37686347Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells: expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells
Q34404759Relationship between microbial translocation and endothelial function in HIV infected patients
Q35198890Relationship between postprandial endotoxemia in nonobese postmenopausal women and diabetic nonobese postmenopausal women
Q26775340Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis
Q87691389Risk of cardiovascular disease in inflammatory bowel disease
Q57111078Role of gut microbiota in chronic low-grade inflammation as potential driver for atherosclerotic cardiovascular disease: a systematic review of human studies
Q34555906Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice
Q37215251Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis
Q54737680Searching for links between endotoxin exposure and pregnancy loss: CD14 polymorphism in idiopathic recurrent miscarriage.
Q73322731Seek and thou shalt find: bacterial lipopolysaccharide as a possible link between increased CD14 expression, high CRP, and low HDL
Q89830662Serum lipopolysaccharide neutralizing capacity in ischemic stroke
Q37456616Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients.
Q49797519South Asian Health: Inflammation, Infection, Exposure, and the Human Microbiome.
Q34093621Sparstolonin B suppresses lipopolysaccharide-induced inflammation in human umbilical vein endothelial cells.
Q38510131Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability
Q36600936Subclinical-Dose Endotoxin Sustains Low-Grade Inflammation and Exacerbates Steatohepatitis in High-Fat Diet-Fed Mice
Q35654379Super-low dose endotoxin pre-conditioning exacerbates sepsis mortality
Q35135904Surfactant protein D is expressed and modulates inflammatory responses in human coronary artery smooth muscle cells
Q33941972Systemic inflammation in cardiovascular and periodontal disease: comparative study
Q34430776T-cell phenotypes, apoptosis and inflammation in HIV+ patients on virologically effective cART with early atherosclerosis
Q35030351The CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte/macrophage activation in treated HIV-infected individuals
Q90733135The Dual Role of Surfactant Protein-D in Vascular Inflammation and Development of Cardiovascular Disease
Q57169434The Human Gut Microbiome - A Potential Controller of Wellness and Disease
Q57492139The Role of Gut Microbiota in Atherosclerosis and Hypertension
Q34297184The alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice
Q38555406The danger model: questioning an unconvincing theory
Q43105112The decrease of serum levels of human neutrophil alpha-defensins parallels with the surgery-induced amelioration of NASH in obesity.
Q36551843The effect of prebiotic supplementation with inulin on cardiometabolic health: Rationale, design, and methods of a controlled feeding efficacy trial in adults at risk of type 2 diabetes
Q90098412The endotoxin hypothesis of neurodegeneration
Q35038619The gut microbiome as novel cardio-metabolic target: the time has come!
Q35042986The gut microbiome, kidney disease, and targeted interventions
Q64927277The heart-gut axis: new target for atherosclerosis and congestive heart failure therapy.
Q42564043The importance of the presence of aggregatibacter actinomycetemcomitans in sulcus gingivalis of patients with cardiovascular diseases
Q37408646The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis
Q33639016Toll-Interacting Protein in Resolving and Non-Resolving Inflammation
Q37421811Translational mini-review series on immunology of vascular disease: inflammation, infections and Toll-like receptors in cardiovascular disease
Q35674383Understanding the expression of Toll-like receptors in Asian Indians predisposed to coronary artery disease
Q36896547Vitamin D3 repletion in chronic kidney disease stage 3: effects on blood endotoxin activity, inflammatory cytokines, and intestinal permeability
Q55025772[Effect of glutaredoxin on oxidative stress of umbilical vein endothelial cell exposed to Porphyromonas gingivalis lipo- polysaccharide].
Q37352012mRNA-binding protein ZFP36 is expressed in atherosclerotic lesions and reduces inflammation in aortic endothelial cells

Search more.